New Releases from NCBI BookshelfRelugolix (Orgovyx): Indication: For the treatment of adult patients with advanced prostate cancer: CADTH Reimbursement Recommendation [Internet].​Relugolix (Orgovyx): Indication: For the treatment of adult patients with advanced prostate cancer: CADTH Reimbursement Recommendation [Internet].

By /

CADTH recommends that relugolix (Orgovyx) should be reimbursed by public drug plans for the treatment of advanced prostate cancer if certain conditions are met.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Useful Links

NEWREDMARS SKILL AND RESEARCH        FOUNDATION

Registration No: 771800548      Contact Number : +91-8249516996

©2021-2024. Newredmars Skill and Research Foundation. All Rights Reserved.

Scroll to Top